endeavor. The knowledge base resulting from this research will have a direct impact on future DON/DoD operations as NP-based diagnostics and therapeutics are already beginning to play a role in the maintenance of warfighter health. Further, this research provides a potential protective/defensive function as it facilitates the design and fabrication of protective countermeasures meant to defeat the potential harmful uses of NP formulations that troops could encounter in the field. PART III: PRESS RELEASE: Dr. Doe spearheaded the implementation of nanoparticle materials in cellular applications (specifically, semiconductor quantum dots (QDs)) for the purposes of cellular labeling, imaging and sensing. Understanding the interaction of nanoparticle materials with living systems is a critical endeavor for DON/DoD and the larger scientific community, as nanoparticles find increasingly more uses in manufacturing processes, medical diagnostics and in therapeutic formulations. In 2013, his work on understanding the cellular uptake and distribution of QDs demonstrated how these materials can be used as superior alternatives to traditional fluorophores for cellular labeling, sensing, cargo delivery and the modulation of cellular behavior. RECOMMENDED CITATION: Dr. Doe developed a new multifunctional peptide-based platform to deliver nanoparticles to cells, thereby opening the ability to target specific cells to receive curative/destructive nanomaterials. This has significantly advanced the nanoparticle research understanding of how to control nanomaterials within cells and how to community’s target cargo delivery to specific sites within an individual living cell. The knowledge base resulting from his research will have a direct impact on future DON/DoD operations as NP-based diagnostics and therapeutics are already beginning to play a role in the maintenance of warfighter health. NOMINATION FOR RECOGNITION PATENTS: Name of Organization: __________________________________________________ Number of Patents in Organization: ___________ Name of Individual: ____________________________________________________
endeavor. The knowledge base resulting from this research will have a direct impact on future DON/DoD operations as NP-based diagnostics and therapeutics are already beginning to play a role in the maintenance of warfighter health. Further, this research provides a potential protective/defensive function as it facilitates the design and fabrication of protective countermeasures meant to defeat the potential harmful uses of NP formulations that troops could encounter in the field. PART III: PRESS RELEASE: Dr. Doe spearheaded the implementation of nanoparticle materials in cellular applications (specifically, semiconductor quantum dots (QDs)) for the purposes of cellular labeling, imaging and sensing. Understanding the interaction of nanoparticle materials with living systems is a critical endeavor for DON/DoD and the larger scientific community, as nanoparticles find increasingly more uses in manufacturing processes, medical diagnostics and in therapeutic formulations. In 2013, his work on understanding the cellular uptake and distribution of QDs demonstrated how these materials can be used as superior alternatives to traditional fluorophores for cellular labeling, sensing, cargo delivery and the modulation of cellular behavior. RECOMMENDED CITATION: Dr. Doe developed a new multifunctional peptide-based platform to deliver nanoparticles to cells, thereby opening the ability to target specific cells to receive curative/destructive nanomaterials. This has significantly advanced the nanoparticle research community’s understanding of how to control nanomaterials within cells and how to target cargo delivery to specific sites within an individual living cell. The knowledge base resulting from his research will have a direct impact on future DON/DoD operations as NP-based diagnostics and therapeutics are already beginning to play a role in the maintenance of warfighter health. NOMINATION FOR RECOGNITION PATENTS: Name of Organization: __________________________________________________ Number of Patents in Organization: ___________ Name of Individual: ____________________________________________________
Preliminary%20Draft%20Guidance%20for%20Web%20Posting.docx